Research Areas

Biotek reached end of a years-long project to bring all software development and support in-house.

To focus its business on cell imaging and handling technologies, Evotec Technologies GmbH sold the core of its single-molecule detection (SMD) technology and related IP.

Schering-Plough Research Institute joins in the scientific collaboration that Hurel has convened to develop “human-on-a-chip” technology.

Avalon and ChemDiv are combining their technologies to seek small molecules active against cancer.

LifeStem Inc., a subsidiary of CalbaTech Inc., introduced a program that collects and banks adult stem cells from two tissue sources in healthy individuals.

Scientists scanned the phosphoprotein profile of acute myeloid leukemia (AML), identifying a novel mutant protein kinase (JAK3) that may drive AML progression

Both parties obtain “substantial freedom” to conduct research under certain of each other’s IP and develop therapeutic, prophylactic and diagnostic products.

Montreal-based Genizon Biosciences occupies a rather unique position in the research of the gene-based diseases.

In a move that is largely aimed at clinical trial-level work but which has implications for drug discovery as well, Stratagene has entered into a joint development and license agreement with Rosetta Inpharmatics LLC.

Lab mice may have competition in modeling human cancer, as scientists at Phylonix Pharmaceuticals successfully modeled various stages of tumor development in zebrafish.